Evidence map›Paper›PMID 19052555›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2009

Acute hemodynamic effects of caffeine administration in premature infants.

V Soloveychik, A Bin-Nun, A Ionchev, S Sriram, W Meadow

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03086473 (A Randomized, Placebo-controlled Trial of Early Caffeine in Preterm Neonates), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03086473 phase4unknown statusnot on this mapstarted 2017, after this paper: background citation

A Randomized, Placebo-controlled Trial of Early Caffeine in Preterm Neonates

TypeinterventionalSponsorJennifer ShepherdRan2017 to 2022Enrolled24ConditionsBPD - Bronchopulmonary Dysplasia, Apnea of Prematurity, Hemodynamic Instability, IntubationArmsCaffeine Citrate, Placebo (Normal Saline)
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Observational
  4. Article
  5. Review
  6. Review
  7. Optimizing respiratory management in preterm infants: a review of adjuvant pharmacotherapies.Journal of perinatology : official journal of the California Perinatal Association · 2021
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Caffeine therapy in preterm infants.World journal of clinical pediatrics · 2015
    Review
  16. Article
  17. Early caffeine therapy and clinical outcomes in extremely preterm infants.Journal of perinatology : official journal of the California Perinatal Association · 2013
    Article
  18. Evaluation of Timing and Dosing of Caffeine Citrate in Preterm Neonates for the Prevention of Bronchopulmonary Dysplasia.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

V SoloveychikNeonatology Section, Department of Pediatrics, Comer's Children Hospital, The University of Chicago, Chicago, IL, USA. vsoloveychik@yahoo.com
A Bin-Nun
A Ionchev
S Sriram
W Meadow
Memorial Hospital of South Bend · USComer Children's Hospital · USMemorial Hospital · USSouth Bend Medical Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAdministration of caffeine citrate (caffeine) has been a central component of the treatment of apnea of prematurity. However, given its multiple pharmacologic effects, caffeine might be expected to produce hemodynamic changes in heart rate, stroke volume, cardiac output and vascular resistance. STUDY

designIn this prospective observational study, we report the hemodynamic effects of intravenous caffeine administration in a population of premature infants who received caffeine to correct or prevent apnea of prematurity.

methodsHemodynamic effects of caffeine were determined in 31 infants. Stroke volume was measured via echocardiogram, using velocity time integral at the aortic root diameter. Statistically univariate analyses were performed parametrically using paired t-test and nonparametrically (sign test). Multivariate linear regression models were used to identify subgroup covariate effects.

resultsAfter intravenous caffeine, cardiac index increased in 31 of 31 trials, by an average of 14.6+/-16.3% (s.d.); stroke volume increased in 24 of 31 trials, by 7.8+/-12.2%; heart rate increased in 28 of 31 trials by 7.7+/-7.2 beats per min; and blood pressure increased in 25 of 31 trials, by 4.1+/-5.8 mm Hg (all P<0.001). Multivariate linear regression revealed no significant effect of dose, birth weight, gestational age or postnatal age.

conclusionsIntravenous caffeine consistently increases cardiac output and blood pressure in relatively stable premature infants, when given to treat or prevent apnea of prematurity. We speculate that there may be a role for caffeine in the hemodynamic treatment of hypotensive/hypoperfused infants.

Indexed as

ApneaCaffeineCentral Nervous System StimulantsCitratesHemodynamicsHumansInfant, NewbornInfant, PrematureInfant, Premature, DiseasesProspective StudiesCaffeinecaffeine citrateCentral Nervous System StimulantsCitrates

Identifiers

PMID19052555
OpenAlexW2005020427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.